AI Science Tracker

XGBoost-guided splice switching identifies NEDD4L exon 13 as a TNBC cell vulnerability

Envisagenics, Inc. · 25 Apr 2024 · medicine

Discovery

XGBoost-guided splice switching identifies NEDD4L exon 13 as a TNBC cell vulnerability

SpliceCore’s XGBoost models used splicing-factor RNA-binding and spliceosome information to nominate NEDD4L exon 13 (NEDD4Le13) and the SSO-0205 binding site. In triple-negative breast-cancer MDA-MB-231 cells, SSO-0205 increased exon inclusion (67% versus 15% control), reduced proliferation and decreased migration by 40–50%; the effects were not observed in the non-tumorigenic MCF10A comparator under the reported assays.

Technology: SpliceCore XGBoost models with SHAP and out-of-bag feature analysis

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: In triple-negative breast-cancer MDA-MB-231 cells, SSO-0205 increased exon inclusion (67% versus 15% control), reduced proliferation and decreased migration by 40–50%; the effects were not observed in the non-tumorigenic MCF10A comparator under the reported assays.
  • Still unknown: Experiments were in vitro, including three breast-cell lines and limited biological replicates; the migration assay used two to three replicates. These results do not establish tumor control in animals, patient benefit, safety or clinical efficacy. The source reports the target as novel in the studied context; this is not evidence that the SSO is a treatment.
  • AI role: The models prospectively nominated the NEDD4L exon-13 splice event, predicted functional SSO binding sites, and prioritized implicated splicing factors. Researchers synthesized selected oligonucleotides and tested splicing, proliferation and migration in cell lines.

Evidence sources: https://link.springer.com/article/10.1038/s44320-024-00034-9

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: at percentile 78 of works of the same type, year and subfield (OpenAlex work metrics, 12 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.